红花如意丸联用甲硝唑联合治疗慢性盆腔炎的疗效及机制探讨
The Curative Effect and Mechanism of Safflower Wishful Pill and Metronidazole in the Treatment of Chronic Pelvic Inflammatory Disease
DOI: 10.12677/ACM.2019.92023, PDF,   
作者: 何小清:遂宁市中心医院,四川 遂宁;汤岭梅:重庆市江津区中医院,重庆
关键词: 慢性盆腔炎红花如意丸甲硝唑Chronic Pelvic Inflammatory Disease Saffron Wishful Pill Metronidazole
摘要: 目的:观察红花如意丸与甲硝唑联合使用治疗慢性盆腔炎的疗效,并对其可能机制作初步探索。方法:从我们医院选取慢性盆腔炎的患者,共计100例,其中对照组(常规治疗 + 甲硝唑)、治疗组(常规治疗 + 甲硝唑 + 红花如意丸)各50例,共治疗3疗程。观察疗效、安全性,并对患者治疗前、后血清中IL-2、IL-4、IL-10、TNF-α及TGF-β1的含量作评价。结果:两组均有一定的疗效,降低VSA评分,缓解疼痛;另外,两组分别与各自治疗前比较,患者血清中IL-2、IL-4、IL-10、TGF-β1的含量均有上升,而TNF-α有下降;两组的治疗后相互比较,则治疗组患者血清中IL-2、IL-4、IL-10、TGF-β1的水平相对更高、TNF-α更低。结论:红花如意丸与甲硝唑联合使用能升高IL-2、IL-4、IL-10、TGF-β1的水平,降低TNF-α的水平,对治疗慢性盆腔炎有不错的临床疗效。
Abstract: AIM: To observe the clinical effect of Saffron wishful pill together with metronidazole on Chronic pelvic inflammatory disease, and explore possible mechanisms. METHODS: Choose 100 cases of the Chronic pelvic inflammatory disease patients from our hospital, and patients were randomly divided into two groups: The control group (conventional treatment + metronidazole), and the treatment group (conventional treatment + metronidazole + safflower wishful pill), with 3 courses of treatment. The curative effect and safety were observed, and the serum levels of IL-2, IL-4, IL-10, TNF-α and TGF-β1 were evaluated before and after treatment. RESULTS: Both groups can reduce VSA score and relieve pain. In addition, the levels of IL-2, IL-4, IL-10 and TGF-β1 in the serum of the two groups were increased compared with those before treatment, and TNF-α decreased. After treatment, the two groups were compared with each other; the serum levels of IL-2, IL-4, IL-10 and TGF-β1 in the treatment group were relatively higher and TNF-α was lower. CONCLUSION: The combination of safflower wishful pill and metronidazole can raise the level of IL-2, IL-4, IL-10 and TGF-β1 and decrease the level of TNF-α, which has a good clinical curative effect in the treatment of chronic pelvic inflammatory disease.
文章引用:何小清, 汤岭梅. 红花如意丸联用甲硝唑联合治疗慢性盆腔炎的疗效及机制探讨[J]. 临床医学进展, 2019, 9(2): 139-145. https://doi.org/10.12677/ACM.2019.92023

参考文献

[1] 张军会, 王永辉, 周文静, 等. 中医辨治慢性盆腔炎经验[J]. 河北中医, 2015, 37(3): 429-430.
[2] 陈再春, 段瑞军. 热敷透骨草组方联合常规西药治疗慢性盆腔炎80例临床观察[J]. 河北中医, 2015, 37(8): 1173-1174.
[3] 焦俊芳. 抗生素、超短波联合血府逐瘀胶囊治疗慢性盆腔炎[J]. 中国实验方剂学杂志, 2011, 17(13): 294-295.
[4] 朱丽萍, 李玉棉. 埋线疗法联合盆腔炎灵治疗慢性盆腔炎30例临床观察[J]. 河北中医, 2014, 36(7): 1002-1003.
[5] 顾曼丽, 徐华国. 浅谈湿热瘀阻型慢性盆腔炎的中医治疗[J]. 中医药临床杂志, 2004, 16(4): 376-377.
[6] 谢幸, 苟文丽. 妇产科学[M]. 第8版. 北京: 人民卫生出版社, 2013: 294-295.
[7] 郑筱萸. 中药新药临床研究指导原则[M]. 北京: 中国医药科技出版社, 2002: 5.
[8] 刘震坤, 金影, 董克勤. 中药保留灌肠治疗气滞血瘀型慢性盆腔炎[J]. 长春中医药大学学报, 2014, 30(5): 866-868.
[9] 陈泽, 郑庆莉. 探究莫西沙星联合桂枝茯苓胶囊对慢性盆腔炎患者血清IL-4、IL-10及TGF-β1的影响[J]. 中国生化药物杂志, 2016, 3(36): 133-137.
[10] Zeng, X.Y., Ling, C. and Ye, Z.Q. (2012) Extracorporeal Shock Wave Treatment for Non-Inflammatory Chronic Pelvic Pain Syndrome: A Prospective, Randomized and Sham-Controlled Study. Chinese Medical Journal, 215, 114-118.
[11] 沈慧敏, 杨越波, 方莉, 等. 金刚藤胶囊治疗慢性盆腔炎临床疗效观察[J]. 中药材, 2009, 30(10): 1340-1343.
[12] 罗艳琴, 马云, 宋路瑶, 等. 菝葜活性成份对慢性盆腔炎大鼠子宫组织肿瘤坏死因子-ɑ和白介素-4的影响[J]. 南方医科大学学报, 2014, 34(2): 236-240.
[13] 权丽丽. 妇炎康联合抗生素对慢性盆腔炎患者血清相关炎症因子表达的影响[J]. 中国医药科学, 2014, 4(3): 71-73.